slow

Antibodies targeting GPNMB may slow Parkinson's disease progression

News Medical May 13, 2026 0Comment

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson’s disease (PD).

Is Earth’s Constant Companion a Stray Asteroid or a Chunk of the Moon?

New mechanism to enhance precision in cancer drug development

Health Psychology

Common air pollutants are linked to higher risks of Lewy body and Parkinson’s dementias

Scientists Found a Hidden “Golden Rule” in Abstract Art — and Your Eyes May Already Know It